Enzyme Replacement Therapy with Idursulfase in Patients with Mucopolysaccharidosis Type II: Literature Review

Enzyme Replacement Therapy with Idursulfase in Patients with Mucopolysaccharidosis Type II: Literature Review

Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is X-linked hereditary disease from the group of lysosomal storage disease. Its prevalence is 3-7 cases per 1 million live-born boys. MPS II occurs due to the deficiency of iduronate-2-sulfatase enzyme because of pathological changes in the str...

Full description

Saved in:
Bibliographic Details
Main Authors: Nato D. Vashakmadze (Author), Natalya V. Zhurkova (Author), Olga B. Gordeeva (Author), Elena V. Komarova (Author), Tatyana E. Privalova (Author), Anastasya I. Rykunova (Author), Marina А. Babaykina (Author)
Format: Book
Published: "Paediatrician" Publishers LLC, 2021-12-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items